BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/25/2023 6:03:15 AM | Browse: 370 | Download: 1109
 |
Received |
|
2023-10-23 15:13 |
|
Peer-Review Started |
|
2023-10-23 15:14 |
|
First Decision by Editorial Office Director |
|
2023-11-22 23:34 |
|
Return for Revision |
|
2023-11-22 23:34 |
|
Revised |
|
2023-11-27 08:40 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-12-05 09:08 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-12-12 07:54 |
|
Articles in Press |
|
2023-12-12 07:54 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-12-15 06:34 |
|
Publish the Manuscript Online |
|
2023-12-25 06:03 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Li Chen |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Li Chen, Doctor, MD, PhD, Doctor, Doctor, Department of Gastroenterology, Ruijin Hospital , Shanghai JiaoTong University, School of Medicine, No. 999 Xiwang Road, Jiading District, Shanghai 201801, China. drchenli@163.com |
| Key Words |
Non-alcoholic fatty liver disease; Metabolic dysfunction-associated fatty liver disease; Metabolic dysfunction-associated steatotic liver disease; Nomenclature; Metabolic risk factors |
| Core Tip |
The nomenclature for non-alcoholic fatty liver disease has undergone name changes twice in a span of three years. However, there exist significant disparities and some consensus between the transition from metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease. Clarifying these discrepancies would greatly benefit clinical practice and trials. |
| Publish Date |
2023-12-25 06:03 |
| Citation |
Chen L. From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus. World J Hepatol 2023; 15(12): 1253-1257 |
| URL |
https://www.wjgnet.com/1948-5182/full/v15/i12/1253.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v15.i12.1253 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
